Capital comprising of the proceeds of the issue of Cell Shares.

Shares created and issued by a Protected Cell Company in respect of one of its cells.

The assets of the Protected Cell Company attributable to the Companyâ€™s Cells.

Liabilities that may be settled by disposition of cellular assets.

The Central Bank of the U.A.E. or its equivalent in another country or territory.

Pursuant to GEN Rule 2.18.1(3), a Person operates as a Central Counterparty where it:

9

GLO/VER62/07-25

Defined Term